article thumbnail

Moderna CFO Exits A Day After Taking Charge With His Annual Pay

HR Digest

Moderna CFO Jorge Gomez had assumed the position just one day prior, almost a month after leaving a dental company. While Moderna looks for a replacement, his recently retired predecessor, David Meline, will continue to work as the CFO. The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11.

CFO 52
article thumbnail

Why You Should Care About The Revenue Forecast

The Idolbuster

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. It is tempting to think that these numbers are scientifically derived and reliable, but often they come from sticking a finger in the air, and then justified after-the-fact in Excel.

article thumbnail

Five Questions Companies Should Ask Before Making an Innovation-Driven Acquisition

Harvard Business Review

In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade. Interestingly, Dominic Caruso also came with the deal for that small biotech company, and he is now the pharma giant's CFO.